Hudson Bay Capital Management LP Amarin Corp Plcuk Transaction History

Hudson Bay Capital Management LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.13 - $3.69 $457,649 - $1.49 Million	-405,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.85 - $3.73 $28,500 - $37,300	-10,000 Reduced 2.41%	405,000 $1.33 Million
Q4 2021 Feb 14, 2022	BUY	$3.24 - $5.18 $615,600 - $984,200	190,000 Added 84.44%	415,000 $1.4 Million
Q3 2021 Nov 15, 2021	SELL	$3.94 - $5.84 $295,500 - $438,000	-75,000 Reduced 25.0%	225,000 $1.15 Million
Q2 2021 Aug 16, 2021	BUY	$4.26 - $6.5 $1 Million - $1.53 Million	235,000 Added 361.54%	300,000 $1.31 Million
Q4 2020 Feb 12, 2021	SELL	$4.04 - $5.31 $585,800 - $769,950	-145,000 Reduced 69.05%	65,000 $318,000
Q3 2020 Nov 12, 2020	BUY	$3.64 - $7.76 $509,600 - $1.09 Million	140,000 Added 200.0%	210,000 $884,000
Q2 2020 Aug 12, 2020	SELL	$4.78 - $8.26 $501,900 - $867,300	-105,000 Reduced 60.0%	70,000 $484,000
Q1 2020 May 14, 2020	BUY	$4.0 - $21.53 $640,000 - $3.44 Million	160,000 Added 1066.67%	175,000 $700,000
Q4 2019 Feb 12, 2020	BUY	$13.94 - $24.12 $209,100 - $361,800	15,000 New	15,000 $322,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $190M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.